| Dr Ali Syed Pervez, DO | |
|
12225 71st St, Kenosha, WI 53142-7320 | |
| (877) 666-7223 | |
| Not Available |
| Full Name | Dr Ali Syed Pervez |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 7 Years |
| Location | 12225 71st St, Kenosha, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679000178 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 34.014622 (Ohio) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 21183 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aurora Medical Group, Inc. | 6709794258 | 3207 |
News Archive
The S. Mark Taper Foundation awarded a grant of $30,000 to Valley Presbyterian Hospital (VPH) for its Stroke Center, a state-of-the-art facility using the latest in telemedicine and diagnostic tools to ensure the best possible outcomes for its patients, Gustavo Valdespino, President and CEO of VPH, announced today.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.
Pleural mesothelioma patients who undergo lung-sparing surgery in combination with photodynamic therapy (PDT) show superior overall survival than patient treated using the conventional therapy of extrapleural pneumonectomy (EPP) with PDT, indicates new research from the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania.
A new study from Cincinnati Children's Hospital Medical Center reports that beverage can stay-tabs pose a potential ingestion risk. In the 1970s, U.S. manufacturers switched to the stay-tab design after safety concerns about pull-tabs. The new study found 19 cases of stay-tab ingestion at a single institution, mainly among teenagers.
› Verified 8 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
The S. Mark Taper Foundation awarded a grant of $30,000 to Valley Presbyterian Hospital (VPH) for its Stroke Center, a state-of-the-art facility using the latest in telemedicine and diagnostic tools to ensure the best possible outcomes for its patients, Gustavo Valdespino, President and CEO of VPH, announced today.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.
Pleural mesothelioma patients who undergo lung-sparing surgery in combination with photodynamic therapy (PDT) show superior overall survival than patient treated using the conventional therapy of extrapleural pneumonectomy (EPP) with PDT, indicates new research from the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania.
A new study from Cincinnati Children's Hospital Medical Center reports that beverage can stay-tabs pose a potential ingestion risk. In the 1970s, U.S. manufacturers switched to the stay-tab design after safety concerns about pull-tabs. The new study found 19 cases of stay-tab ingestion at a single institution, mainly among teenagers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ali Syed Pervez, DO 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (877) 666-7223 | Dr Ali Syed Pervez, DO 12225 71st St, Kenosha, WI 53142-7320 Ph: (877) 666-7223 |
News Archive
The S. Mark Taper Foundation awarded a grant of $30,000 to Valley Presbyterian Hospital (VPH) for its Stroke Center, a state-of-the-art facility using the latest in telemedicine and diagnostic tools to ensure the best possible outcomes for its patients, Gustavo Valdespino, President and CEO of VPH, announced today.
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.
Pleural mesothelioma patients who undergo lung-sparing surgery in combination with photodynamic therapy (PDT) show superior overall survival than patient treated using the conventional therapy of extrapleural pneumonectomy (EPP) with PDT, indicates new research from the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania.
A new study from Cincinnati Children's Hospital Medical Center reports that beverage can stay-tabs pose a potential ingestion risk. In the 1970s, U.S. manufacturers switched to the stay-tab design after safety concerns about pull-tabs. The new study found 19 cases of stay-tab ingestion at a single institution, mainly among teenagers.
› Verified 8 days ago
Dr. Pushparanee Babusukumar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3535 30th Ave, Suite 201, Kenosha, WI 53144 Phone: 262-652-7813 Fax: 262-652-4450 | |
Dr. Jimmy Viet Ninh, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-7815 | |
Dr. Mathew Sean Mccarthy, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3536 52nd St, Kenosha, WI 53144 Phone: 262-657-1090 | |
Dr. Saritha Kundoor, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Anna Klyachkina, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12225 71st St, Kenosha, WI 53142 Phone: 262-948-4870 | |
Dr. Vanessa Q Chang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, #307, Kenosha, WI 53142 Phone: 262-948-6770 | |
Ronald Rubin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3734 7th Ave Ste 12, Kenosha, WI 53140 Phone: 262-654-9370 Fax: 262-654-9379 |